SCHEMBL14547312

SCHEMBL14547312

C=C/C=C\C(=C/C)Nc1cc(C2CCN(C(=O)OCc3ccccc3)CC2)nc2c(Br)cnn12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPC3 Q13507 2/20 0.43
▸ TRPC7 Q9HCX4 2/20 0.43
▸ GSK3B P49841 3/20 0.41
▸ TGM2 P21980 3/20 0.39
▸ TGM1 P22735 3/20 0.39
▸ BTK Q06187 1/20 0.39
▸ GRIN2B Q13224 4/20 0.38
▸ F13A1 P00488 2/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ JAK2 O60674 2/20 0.37
▸ JAK1 P23458 2/20 0.37
▸ TYK2 P29597 2/20 0.37
▸ JAK3 P52333 2/20 0.37
▸ USP30 Q70CQ3 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14547159 0.92 GSK3B (0.40) TRPC3TRPC7GSK3BTGM2TGM1
SCHEMBL13993128 0.82 TRPC3 (0.49) TRPC3TRPC7GSK3BGRIN2BSMN1; SMN2
SCHEMBL12954092 0.81 GSK3B (0.49) TRPC3TRPC7GSK3BGRIN2BSMN1; SMN2
SCHEMBL13998619 0.80 GRIN2B (0.52) TRPC3TRPC7GSK3BGRIN2BSMN1; SMN2
SCHEMBL14547315 0.79 GSK3B (0.48) GSK3B
SCHEMBL11931136 0.79 GSK3B (0.51) TRPC3TRPC7GSK3BGRIN2BCYP2D6
SCHEMBL12953546 0.79 TRPC3 (0.53) TRPC3TRPC7GSK3BGRIN2BSMN1; SMN2
SCHEMBL13998618 0.78 GSK3B (0.54) TRPC3TRPC7GSK3BGRIN2BSMN1; SMN2
SCHEMBL12953650 0.78 GSK3B (0.54) TRPC3TRPC7GSK3BGRIN2BSMN1; SMN2
SCHEMBL12953929 0.78 GSK3B (0.71) GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044401-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback